about
Emerging drugs for psoriatic arthritis.Spondyloarthritis with onset after age 45.Safety of anti-tumor necrosis factor agents in psoriatic arthritis - an update.An update on the management of hepatitis C virus-related arthritis.Pharmacological therapy of spondyloarthritis.Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis.Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis.Ochronotic arthropathy of the spine limited to the thoracic section
P50
Q37763192-55EBE495-AD03-4C48-85ED-EB46459C062CQ38156342-18974AAD-AC2D-4712-92DA-2E888FD5E778Q38161956-105377C8-F7C7-4F5B-8F87-9075CA90A729Q38242116-A9AB7EA6-FB66-4A41-BB96-7F6FD9C84957Q38527552-3AC45762-9507-4E8E-B4F2-CA7EF433493DQ43295202-9453CE19-78F0-498E-B103-45AD482F0AA2Q51738074-ECD67F9E-3274-4FF8-B735-A3D599B0E3D6Q51828458-9BA30B2D-74AD-4C03-8B6E-32E5D30F2378Q85856822-1CD34FE4-CED8-4180-903C-D1E90B72AA14
P50
description
researcher ORCID ID = 0000-0001-9642-1376
@en
wetenschapper
@nl
name
Pietro Leccese
@ast
Pietro Leccese
@en
Pietro Leccese
@es
Pietro Leccese
@nl
type
label
Pietro Leccese
@ast
Pietro Leccese
@en
Pietro Leccese
@es
Pietro Leccese
@nl
prefLabel
Pietro Leccese
@ast
Pietro Leccese
@en
Pietro Leccese
@es
Pietro Leccese
@nl
P1153
26435346400
P31
P496
0000-0001-9642-1376